Price:
Rs. 627.00
Sample Type: Blood
Fasting Not Required
Booking Procedure:
- Technician from Thyrocare will be assigned for a free home sample collection after booking confirmation.
- Sample will be collected by our technician at your address at given slot.
- You will get a payment link in 2 hours. You can make the payment online or pay cash to the technician.
- Soft copy reports will be sent to your email address within 24 to 48 hours.
Frequently Asked Questions (FAQ's):
1. What is included in the Thyrocare Apo A1 Test?
The Thyrocare Apolipoprotein A1 (Apo A1) Test measures the level of Apo A1, a major protein component of HDL (good cholesterol) in the blood. It helps assess cardiovascular risk and lipid metabolism.
2. Who should opt for the Thyrocare Apo A1 Test?
This test is recommended for individuals with a family history of heart disease, abnormal cholesterol levels, or those undergoing cardiovascular risk assessments. It is also useful for monitoring lipid-lowering therapy.
3. Is fasting required before taking the Thyrocare Apo A1 Test?
Fasting is not strictly necessary.
However, your doctor may recommend a fasting sample for a complete lipid profile assessment.
4. How is the sample collected for the Thyrocare Apo A1 Test?
A blood sample is collected at your home by a trained technician and analyzed using immunoturbidimetric methods at Thyrocare’s NABL- and ISO-certified laboratories. We provide home sample collection and a digital report.
5. What is the cost of the Thyrocare Apo A1 Test?
The test is priced at RS 627.
6. When will I receive my Thyrocare test reports?
You will receive your report within 10 to 24 hours of sample collection via SMS and email.
7. Is the Thyrocare Apo A1 Test available across India?
Yes, this test is available across India, covering metro cities, towns, and rural regions.
8. What makes the Thyrocare Apo A1 Test reliable?
Thyrocare uses automated analyzers and standardized reagents under strict quality control protocols, ensuring accurate assessment of HDL functionality and heart disease risk.